Table 3

Total expenditure and reimbursement percentages for patients with prostate cancer and bone metastasis in Beijing from 2011 to 2014 (per patient per year)*

YearSettingNMeanSDMedianQ1Q3%†
2011Outpatient3105503.36137.73416.01609.66773.793.0%
Inpatient26512 726.813 469.97536.33322.817 701.087.4%
Total32215 772.116 942.69360.24328.921 147.689.3%
2012Outpatient4476959.06976.34870.72389.58975.793.1%
Inpatient39013 745.015 243.18551.33507.118 323.388.0%
Total45818 496.218 931.611 704.75974.424 070.189.9%
2013Outpatient5526992.46990.64454.32137.98897.593.0%
Inpatient45113 555.314 713.58411.03381.918 909.887.9%
Total55817 873.318 562.811 144.64789.124 630.889.9%
2014Outpatient5996844.86829.14258.42439.78854.692.8%
Inpatient49414 218.614 890.79529.84431.419 005.086.0%
Total61118 206.318 700.211 801.05612.824 711.688.5%
  • *Based on all visits. Q1 = 25% quartile/Q3 = 75% quartile.

  • †The proportion of treatment costs reimbursed by Urban Employee Basic Medical Insurance. SD, standard deviation.